“The digitalisation megatrend will radically change traditional insurance. It will give rise to new fields of risk in need of insurance solutions. With its numerous digital and innovation projects, Munich Re has laid the foundations for profitable growth going forward”, says Munich Re’s Board member Torsten Jeworrek.
Munich Re has kept the rising ransomware losses in its book of business readily manageable. In addition, price increases in a hardening market environment are producing a stabilising effect. Munich Re is adhering to its plan to grow profitably based on a current market share of roughly 10%.
Category:
Pandemic
Latest
Biden to outline plan to curb coronavirus Delta variant as cases grow
Reuters data shows that more than 20,800 people have died in the United States from COVID-19 in the past two weeks, up about 67% from the prior two-week period. Hospitalizations have grown, with seven U.S. states – Alaska, Georgia, Hawaii, Idaho, Kentucky, Tennessee and Washington – reporting records this month.
According to the U.S. Centers for Disease Control and Prevention, 62.3% of Americans have received at least one vaccine dose and 53% – 176 million people – are fully vaccinated.
India continues to “lag way behind” in COVID vaccination: Fitch
”The (APAC) region which was so successful in containing the virus early on, got behind the curve when it came to rollout of vaccines. Singapore really stands out now with 80 per cent of its population being vaccinated. But many countries in the region like Vietnam, Thailand and India continue to lag way behind and as a result continue to have periodic restrictions,” Schwartz said.
New COVID-19 strain spreads more quickly, UK medical chief says
“As a result of the rapid spread of the new variant, preliminary modelling data and rapidly rising incidence rates in the South East, the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) now consider that the new strain can spread more quickly.
Govt must indemnify vaccine makers against all lawsuits: Adar Poonawalla
“We need to have the government indemnify manufacturers, especially vaccine manufacturers, against all lawsuits. In fact, COVAX and other countries have already started talking about that,” Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla . said.
It is because when frivolous claims come up, and something is blown out of proportion in the media, skepticism sets in that definitely something can happen due to the vaccine and to dispel that, the government needs to step in to spread the right information,
He also said that the vaccine makers are going to propose this to the government,
Is Covid-19 Vaccine a victory for Big Pharma
It’s an incredible public relations coup for an industry desperate to rescue its image. Just last month, Purdue Pharma pleaded guilty and has agreed to penalties of more than $8 billion after being prosecuted for its role in America’s horrific opioid crisis. Pfizer set an earlier record for a drug industry fraud settlement in 2009 at $2.3 billion, in a case over its fraudulent marketing of a painkiller, an antipsychotic and other drugs for conditions for which it hadn’t received approval.The turpitude of the pharmaceutical industry is so commonplace that it has become part of the cultural wallpaper. The screenwriters of the 1993 movie
India at cusp of authorizing 1st set of Covid-19 vax, to cover around 30 cr targeted population: Harsh Vardhan
Observing the fact that despite festivals in October and November, Vardhan said no new surge of cases was observed in this period due to comprehensive testing, tracking and treatment policy implemented on the ground.
The Minister said that India’s Covid-19 pandemic growth has dropped to 2 per cent and the case fatality rate is amongst the lowest in the world at 1.45 per cent.
Insurers, drugmakers sail into unknown with COVID vaccine rollout
Prices for new contracts in the transport insurance market were climbing sharply even before the pandemic following rising claims and reduced competition, and industry sources expect insurance rates to jump when pharma companies involved in COVID-19 vaccines renew their annual policies next year, given the additional risk
Some vaccine doses kept too cold, Pfizer having manufacturing issues, U.S. officials say
Officials are investigating whether storing the vaccines at excessively cold temperatures poses a safety or efficacy risk, he said.
Virus spread like wild fire over ineffective policy implementation: SC
The bench, also comprising Justices R S Reddy and M R Shah, said that frontline health care workers including doctors and nurses are already exhausted physically and mentally due to tireless work for eight months and some mechanism may be needed to give them intermittent rest.
Coronavirus nearly three times more deadly than flu: study
Catherine Quantin, a professor at the University Hospital of Dijon and the French national health institute INSERM who jointly led the study, said the difference in death rates was “particularly striking” given the 2018/19 flu season was the deadliest France had seen in five years.
Keep blood sugar in control to stay fight Covid-19: Experts
People with high blood sugar levels have less than normal blood flow, which makes it difficult for the body to harness nutrients, natural defences meant to protect the body against several infections and promote healing.
UN head stresses need of virus vaccine for all nations
Across the globe we have seen how populist approaches that ignore science have misled the public,” Guterres said. “Coupled with false news and wild conspiracies, things have become manifestly worse.”